News and Info

Welcome to the News and Information section of the ECOG-ACRIN Cancer Research Group website. The materials posted in this section are intended to keep constituents informed of the latest news and activities of the organization. The information below includes press releases, announcements, media advisories, and links to news articles.

We welcome inquiries from members of the press regarding the information posted on this website. To place a media inquiry, contact the Office of Communications.


Latest News

February 27, 2026

Attention CRAs: Travel funds are available for the Spring 2026 Group Meeting (apply now)

February 27, 2026

Attention APPs: Travel funds are available for the Spring 2026 Group Meeting (apply now)

February 27, 2026

Attention radiation oncologists and trainees: Travel funds are available for the Spring 2026 Group Meeting (apply now)

February 13, 2026

The Winter 2026 advocacy blog Considering Clinical Trials is now available

February 9, 2026

Natasha Edwin, MD, community co-chair of the ECOG-ACRIN Myeloma Committee, highlights why patients in rural areas need access to quality clinical trials

February 3, 2026

ECOG-ACRIN legacy lung cancer studies E1594 and E5508 cited in ASCO Living Guideline 2026.3.0, therapy for stage 4 NSCLC without driver alterations

January 31, 2026

The January 2026 News from ECOG-ACRIN blog is now available

January 29, 2026

Press Release: New England Journal of Medicine publishes phase 3 PATINA (PrECOG PrE0111) trial data demonstrating a significant progression-free survival benefit with palbociclib in metastatic HR+, HER2+ breast cancer

January 21, 2026

ECOG-ACRIN study identifies high rates of vulnerability in AML patients aged 60 years or older

January 8, 2026

WATCH: Drs. Jen Specht and Heather Jacene discuss the FEATURE (EA1183) trial results…a game-changer for bone-dominant metastatic breast cancer

January 8, 2026

AI models advance individualized breast cancer recurrence risk assessments

January 8, 2026

Caris, cooperative groups advancing AI models that can improve breast cancer risk assessments (access requires free registration)

January 8, 2026

WATCH: Dr. Joe Sparano discusses a new AI tool for breast cancer recurrence screening

January 4, 2026

JAMA publishes ALCHEMIST EA5142 results: Nivolumab does not further reduce risk of recurrence in non-small cell lung cancer patients who completed standard post-surgery treatment

December 22, 2025

The December 2025 News from ECOG-ACRIN blog is now available

December 22, 2025

WATCH: Dr. Joe Sparano talks with LinkedIn News about using AI for predicting breast cancer recurrence

December 11, 2025

Press Release: An ECOG-ACRIN imaging study solves a long-standing gap in metastatic breast cancer research and care: accurately measuring treatment response in patients with bone metastases

December 10, 2025

Press Release: ECOG-ACRIN and Caris Life Sciences unveil first findings from a multi-year collaboration to advance AI-powered multimodal tools for breast cancer recurrence risk stratification

December 3, 2025

NIH implements “zero-embargo” revisions to its public access policy for published scientific research

December 3, 2025

37 Member Networks and Programs Receive Commendations in 2025 for Research Performance

 
ECOG-ACRIN Cancer Research Group